Snow Lake Resources 주식 (NASDAQ: LITM)

에 대한 최신 뉴스 Snow Lake Resources (NASDAQ:LITM) 주식

Snow Lake Resources

Snow Lake Resources Ltd is a Canadian clean energy exploration company with a world-wide portfolio of clean energy mineral projects comprised of two uranium projects and two hard rock lithium projects. Its Projects include: The Black Lake Uranium Project, the Engo Valley Uranium Project, The Shatford Lake Project, and the Snow Lake Lithium Project.

Snow Lake Resources Ltd

Litman Gregory Funds Trust IMGP Berkshire Dividend Growth ETF

Litman Gregory Funds Trust Im Rba Responsible Global Allocation ETF

Litman Gregory Funds Trust Polen Capital China Growth ETF

Litman Gregory Funds Trust Polen Capital Emerging Markets ex China Growth ETF

Litman Gregory Funds Trust Polen Capital Global Growth ETF

Litman Gregory Funds Trust Polen Capital International Growth ETF

Litman Gregory Funds Trust iMGP DBi Hedge Strategy ETF

Jefferies analyst David Chiaverini initiates coverage on Axos Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AX#NYSE">AX</a>) with a Buy rating and announces Price Target of $90.

News

Price Target

Initiation

Analyst Ratings

Jefferies Initiates Coverage On Axos Financial with Buy Rating, Announces Price Target of $90

NCEW

New Century Logistics Says Says NCEW Investment Consultancy Company Limited Reaches Strategic Cooperation With JDL UK To Jointly Create A New Benchmark Of The Global Integrated Logistics Services

Management

CNMD

CONMED Appoints Laverne Council To Succeed Martha Goldberg Aronson As Independent Chair Of The Board Of Directors, Effective May 21, 2025

CFSB Bancorp, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFSB#NASDAQ">CFSB</a>) shares are surging premarket Wednesday after the company announced on Tuesday that it, along with its subsidiary, Colonial Federal Savings Bank, had entered into a definitive merger agreement to be acquired by <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45532517/hometown-financial-group-inc-to-acquire-cfsb-bancorp-inc" rel="noreferrer noopener">Hometown Financial Group, Inc.</a>
As per the deal, CFSB shareholders will receive $14.25 in cash per share, valuing the transaction at approximately $44 million. The boards of both companies have unanimously approved the deal.
The merger is expected to close in the fourth quarter of 2025, pending regulatory and CFSB shareholder approvals, among other standard conditions.
Also Read: <a href="https://www.benzinga.com/25/05/45534527/china-warns-of-legal-retaliation-against-us-chip-sanctions-threatens-lawsuits-for-aiding-discriminatory-tech-crackdown">China Warns Of Legal Retaliation Against US Chip Sanctions, Threatens Lawsuits For Aiding &#8216;Discriminatory&#8217; Tech Crackdown</a>
Post-acquisition, Colonial Federal Savings Bank will merge into North Shore Bank, forming a $3.3 billion entity with 29 branches spanning Massachusetts&#8217; North and South Shores and southern New Hampshire.
Matthew S. Sosik, chairman and CEO of Hometown Financial Group, said, &#8220;This merger will increase our presence in eastern&nbsp;Massachusetts, and we&#8217;re eager to share the power and resources of Hometown Financial Group and North Shore Bank with the employees and customers of Colonial Federal.&#8221;
Upon completion, Hometown will boast nearly $6.9 billion in consolidated assets and a 56-office network across Massachusetts, southern New Hampshire, and northeastern Connecticut.
Sosik added, &#8220;Our holding company structure offers the best of both worlds to our customers, employees, and communities. Each bank is deeply rooted in the neighborhoods they call home, so each can harness their own local branding power while leveraging an expansive, best-in-class array of shared operational resources and technology, which allow us to take advantage of size, scale, and efficiency.&#8221;
CFSB and Colonial Federal Savings Bank President and CEO&nbsp;Michael E. McFarland added, &#8220;This transaction partners two outstanding banking organizations and represents another step for us in ensuring our long-term success. Colonial Federal customers will enjoy enhanced products and services, innovative digital banking tools, and an expanded branch network to help meet their evolving needs.&#8221;
As of March 31, 2025, CFSB&#8217;s cash and cash equivalents <a href="https://www.benzinga.com//node/45084237" target="_blank" rel="noreferrer noopener">stood at $1.3 million</a>.
Price Action: CFSB shares are up 73.70% at $13.67 premarket at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45533872/cathie-wood-just-spent-8-4-million-on-this-top-chip-stock-and-its-not-nvidia">Cathie Wood Just Spent $8.4 Million On This Top Chip Stock (And It&#8217;s Not NVIDIA)</a></li>
</ul>
Image via Shutterstock

Equities

Small Cap

Movers

CFSB

CFSB Bancorp Shareholders Set For Big Payday As Hometown Financial Group Buys Out

Jefferies analyst David Chiaverini initiates coverage on Flagstar Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) with a Buy rating and announces Price Target of $15.

Jefferies Initiates Coverage On Flagstar Financial with Buy Rating, Announces Price Target of $15

Tango Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>), a clinical-stage biotechnology company committed to discovering the next generation of precision cancer medicines, today announced that the first patient has been dosed in the TNG456 Phase 1/2 trial in patients with MTAP-deleted solid tumors, with a focus on glioblastoma (GBM). TNG456 is a next-generation, brain-penetrant, MTA-cooperative PRMT5 inhibitor.
The Phase 1/2 clinical trial (<a href="https://www.globenewswire.com/Tracker?data=JIMO_jzZSt6mqaqrqmYGz1o9qC54dwUMFXx4EoNCEgkGIBaAxZD_wiY81w6iF_dw-XXPZpoGu5fobSvjqOa7GYCwUjghjdQNuwzzbsV-ZzlEP1hGJnp_RiIBqVKXE9baSt7Pd2L09-motfFQGjJ55Q==">NCT06810544</a>) is evaluating the safety, pharmacokinetics, pharmacodynamics and antitumor activity of TNG456 as a monotherapy and in combination with abemaciclib. We are currently enrolling patients with TNG456 monotherapy in dose escalation focused on GBM.

TNGX

Tango Therapeutics Announces First Patient Dosed In TNG456 Phase 1/2 Trial In Patients With MTAP-Deleted Solid Tumors, With Focus On Glioblastoma

Needham analyst Bernie McTernan reiterates Wix.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>) with a Buy and maintains $250 price target.

Reiteration

Needham Reiterates Buy on Wix.com, Maintains $250 Price Target

Kevin O'Leary says the simplest path to millionaire status starts with one habit: siphon "15% of your income … and invest it in the index of the S&amp;P 500."
What Happened: The Shark Tank investor hit X with the prescription this week, insisting savers don't need to pick winners — or even "understand what a stock is" — to build real wealth.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The key to success on saving is to take 15% of your income when you&#39;re in your 20s and invest it in the index of the S&amp;P 500. You don&#39;t have to pick stocks and you don&#39;t even have to understand what a stock is, but over the period of your life, if you&#39;re taking that 15% every two… <a href="https://t.co/iuOQLaYE75">pic.twitter.com/iuOQLaYE75</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1924532379504542081?ref_src=twsrc%5Etfw">May 19, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
He doubled down on the math: "If you're taking that 15% every two weeks/month on an average salary, you'll end up a millionaire when you're 65 plus. … So it's about learning how to not buy sh&#x2A;t you don't need and investing that money instead." O'Leary framed the strategy as anti-debt armor, arguing index funds beat the temptation of ill-timed trades.
See also: <a href="https://www.benzinga.com/25/05/45513216/mark-cuban-took-a-chance-on-a-20-year-olds-cold-emailthat-350k-bet-helped-launch-a-46-billion-tech-giant">Mark Cuban Took A Chance On A 20-Year-Old&#8217;s Cold Email: That $350 Thousand Bet Helped Launch A $4.6 Billion Tech Giant</a>
Long-term data backs him up. The S&amp;P 500 has delivered more than a 10% annualized return since 1957, smoothing out crashes and recessions along the way, according to Investopedia <a href="https://www.investopedia.com/when-to-invest-in-sp-500-11735415">research</a>.
Personal-finance evangelist Dave Ramsey <a href="https://in.benzinga.com/personal-finance/25/03/44476778/author-says-dave-ramsey-is-completely-ignorant-of-sequence-of-returns-risk-questions-whether-1-million-is-really-enough-for-retirement">echoes the formula</a>, urging followers to "invest 15% of your income in tax-advantaged retirement accounts." Vanguard founder Jack Bogle spent decades <a href="https://www.benzinga.com/general/education/18/08/12290408/this-day-in-market-history-vanguard-launches-first-index-fund-for-u">preaching the same</a> low-cost gospel, while Warren Buffett told his own heirs to park 90% of their inheritance in a <a href="https://www.benzinga.com/markets/25/01/43388711/warren-buffett-believes-this-index-fund-is-the-best-option-for-everyday-investors">cheap S&amp;P tracker</a>.
That said, skeptics are abound. Personal-finance guru Robert Kiyosaki, earlier this week, <a href="https://x.com/theRealKiyosaki/status/1924170242609275368">dismissed index funds</a> and ETFs as mere "paper assets," urging investors to flee to hard assets like gold, silver and Bitcoin instead. According to a MarketWatch <a href="https://www.marketwatch.com/story/bill-ackman-actually-had-a-point-with-his-index-fund-bubble-theory-2016-01-30">article</a>, hedge-fund titan Bill Ackman likewise warned in his 2016 Pershing Square letter that massive inflows are inflating benchmark constituents and creating an "index-fund bubble." David Einhorn, on the other hand, says the dominance of passive strategies has "<a href="https://www.ft.com/content/260079a7-9b08-4dbd-909f-08c2407d1912">fundamentally broken</a>" market structure by siphoning capital from active managers and concentrating power in a few megacap stocks.
Photo Courtesy: Tada Images On Shutterstock.com
Read next: <a href="https://www.benzinga.com/25/05/45513154/trump-tariffs-triggered-price-surgeimports-hit-first-but-made-in-usa-goods-caught-in-the-crossfire-harvard-study-finds">Trump Tariffs Hit Imports For Sure, But Made In USA Purchases Also Didn&#8217;t Escape Price Rise Gauntlet, Shows Harvard Study</a>

Financial Advisors

Personal Finance

Kevin O'Leary Says This One Habit Alone Could Make You A Millionaire And You Don't Even Have To Bother Learning About Stocks

Accenture plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACN#NYSE">ACN</a>) disclosed on Tuesday that it is offering an <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45532971/accenture-collaborates-with-dell-technologies-and-nvidia-to-accelerate-enterprise-ai-transformatio" rel="noreferrer noopener">artificial intelligence solution</a> in partnership with Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) and NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
This partnership expands the Accenture AI Refinery platform, enabling one-click deployment of agentic AI capabilities on Dell&#8217;s high-performance, NVIDIA-accelerated infrastructure.
This will help companies, particularly those within regulated industries or those with substantial investments in on-premises infrastructure, to accelerate value realization and reduce the total cost of ownership.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/25/05/45484071/wall-streets-sugar-rush-bill-gates-on-tariffs-and-a-600-billion-saudi-deal-top-economics-updates-this-week" rel="noreferrer noopener">Wall Street&#8217;s &#8216;Sugar Rush,&#8217; Bill Gates On Tariffs And A $600 Billion Saudi Deal: Top Economics Updates</a>
Furthermore, Accenture will support AI implementation using the NVIDIA Enterprise AI Factory validated design, a framework for organizations to build on-premise AI factories utilizing NVIDIA Blackwell and a broad network of AI partners.
The company delivers on key needs: data sovereignty and compliance, resilience and high availability, robust security for isolated networks, ultra-low latency for real-time uses, and edge/offline capabilities for remote environments.
&#8220;Through this collaboration with Dell Technologies and NVIDIA, Accenture is bringing the power of AI Refinery to on-premises infrastructure, providing an open, interoperable, scalable, and secure solution that paves the way for widespread AI adoption,&#8221; said Lan Guan, chief AI officer, Accenture.
Ihab Tarazi, Chief Technical Officer and Senior Vice President of Dell Technologies, added, &#8220;This solution allows customers to tailor their strategies and engineered architectures to meet diverse needs, ensuring data integrity and protection to accelerate digital transformation.&#8221;
&#8220;Regulated industries face the unique challenge of harnessing AI to drive innovation and efficiency while rigorously adhering to complex compliance, data privacy, and governance standards,&#8221; said Justin Boitano, vice president of Enterprise AI Products, NVIDIA. &#8220;Together, NVIDIA, Accenture, and Dell deliver a turnkey AI platform for enterprises to accelerate transformation, unlock new value from data, and confidently scale AI in alignment with operational requirements.&#8221;
In a separate release, Accenture and&nbsp;SAP SE ADS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAP#NYSE">SAP</a>) disclosed the launch of ADVANCE, a joint initiative aimed at accelerating cloud adoption and business transformation for&nbsp;companies with annual <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45527622/accenture-sap-launch-advance-to-boost-cloud-adoption-for-mid-sized-firms" rel="noreferrer noopener">revenue of up to $5 billion</a>.
Investors can gain exposure to ACN stock via Trust for Professional Managers Jensen Quality Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JGRW#NYSE">JGRW</a>) and SMI 3Fourteen Full-Cycle Trend ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCTE#NASDAQ">FCTE</a>).
Price Action: Shares of Accenture, Dell, and NVIDIA were all trading lower in premarket at last check Wednesday, with ACN down 0.46% at $318.70, DELL down 1.22% at $112.84, and NVDA down 1.15% at $132.84.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/space/25/05/45430526/as-elon-musk-secures-saudi-starlink-deal-elizabeth-warren-and-senate-democrats-demand-probe-into-possible-ethics-violations-and-accuse-trump-administration-of-helping-spacex-secure-foreign-deals" target="_blank" rel="noreferrer noopener">As Elon Musk Secures Saudi Starlink Deal, Elizabeth Warren And Senate Democrats Demand Probe Into Possible Ethics Violations And Accuse Trump Administration Of Helping SpaceX Secure Foreign Deals</a></li>
</ul>
Image by AKOBCHUK V via Shutterstock

Large Cap

Tech

DELL

FCTE

Trust for Professional Managers Jensen Quality Growth ETF

JGRW

NVDA

Accenture, Dell, NVIDIA Deliver On-Premise AI Solution For Regulated Industries

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the financial sector.
<h3 class="wp-block-heading">AGNC Investment Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGNC#NASDAQ">AGNC</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 15.67%</li>
<li>RBC Capital analyst Kenneth Lee maintained an Outperform rating and lowered the price target from $11 to $10 on April 29, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Argus Research analyst Kevin Heal reiterated a Hold rating on April 29, 2025. This analyst has an accuracy rate of 62%.</li>
<li>Recent News: On April 21, AGNC Investment posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">latest AGNC news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="902" height="831" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260.png" alt="" class="wp-image-922406" style="width:614px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042700/image-260-768x708.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">MFA Financial, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MFA#NYSE">MFA</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 14.52%</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained an Outperform rating and cut the price target from $12.5 to $12 on May 8, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Wedbush analyst Jay McCanless maintained an Outperform rating and raised the price target from $13 to $14 on Aug. 9, 2025. This analyst has an accuracy rate of 87%.</li>
<li>Recent News: On May 6, MFA Financial posted mixed quarterly results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest MFA <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="902" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261.png" alt="" class="wp-image-922407" style="width:587px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042730/image-261-768x700.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<h3 class="wp-block-heading">Annaly Capital Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 14.22%</li>
<li>Keefe, Bruyette &amp; Woods analyst Bose George maintained an Outperform rating and raised the price target from $20.15 to $20.5 on May 2, 2025. This analyst has an accuracy rate of 72%.</li>
<li>JP Morgan analyst Richard Shane maintained an Overweight rating and slashed the price target from $21 to $19 on April 16, 2025. This analyst has an accuracy rate of 68%.</li>
<li>Recent News: On April 30, Annaly Capital Management posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521">latest NLY news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0521"><img loading="lazy" decoding="async" width="902" height="822" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262.png" alt="" class="wp-image-922409" style="width:565px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262.png 902w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262-300x273.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/21042803/image-262-768x700.png 768w" sizes="(max-width: 902px) 100vw, 902px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/25/05/45535402/target-lowes-and-3-stocks-to-watch-heading-into-wednesday">Target, Lowe&#8217;s And 3 Stocks To Watch Heading Into Wednesday</a> </li>
</ul>
Photo via Shutterstock

Dividends

Markets

Trading Ideas

AGNC

Wall Street's Most Accurate Analysts Weigh In On 3 Financial Stocks With Over 10% Dividend Yields

Purple Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBT#NASDAQ">PPBT</a>) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.06) by 183.33 percent. This is a 93.93 percent increase over losses of $(2.80) per share from the same period last year.

Earnings

Earnings Misses

PPBT

Purple Biotech Q1 EPS $(0.17) Misses $(0.06) Estimate

<a href="https://www.globenewswire.com/Tracker?data=Pmiif8Cl_kq7ts0rpuWWjwzbuqMZTNz8o1Oqr8EoImm_YPVnP91vEizqwi_P6nhL5UU8A3mmGGVAoQYRsHMHEiUQpF2kXpkFvQAjfuhFzKO-JCOirmdu1LU9r_MBmkTKWkBWR8DXC8RhwbeQxwzOuK8FB5w1uLS6yjjVWVfbHbKnT_ti5XxLoSYfpRBP5dOKfpdvjJt93-66WGQ54M8v8A==">Aduro Clean Technologies Inc.</a> ("Aduro" or the "Company") (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that it has engaged <a href="https://www.globenewswire.com/Tracker?data=rvYmSGASciNtf-ITvELjk-cBnw929gXAkxIGS43_UO3HW93tPLTDrlH7IbQ9bYF-vlPMSkIBN3miyS-rknwaZegc7kytm3RCf2iiloctNH_SZsUapqHlyBZna03KQcpY0Eh9JVPOWapy-2fobugI80IuWXepnAxuiuIGoQ7Xk6s=">Delphi</a>, a leading Canadian sustainability consultancy, to conduct a Life Cycle Assessment ("LCA") of the Company's Hydrochemolytic&#x2122; technology for waste plastic processing.
Delphi is a strategic consulting firm with 35 years of experience, specializing in corporate sustainability, climate change, the green economy, and cleantech innovation. The LCA is part of Aduro's strategic roadmap to independently assess and quantify the environmental performance of its chemical recycling platform through a phased, data-driven process. With increasing regulatory and market emphasis on measurable environmental outcomes, the LCA provides a foundation for engaging stakeholders with credible, third party-reviewed information. Additionally, the LCA will provide critical data to assist in identifying and minimizing inefficiencies and energy consumption throughout the process, assisting in maximizing resource efficiency and reducing operational costs.
The project will begin with a screening-level LCA focused on greenhouse gas ("GHG") emissions and energy use, associated with operating the Hydrochemolytic&#x2122; technology process. This assessment, based on pre-pilot-scale performance data and forward-looking design parameters, will follow <a href="https://www.globenewswire.com/Tracker?data=D2byHyj0nOkdqQZ04onCVjrDzFO09aPWyvQVrtaz3AJAi_Uiu-UlK3g6_ZnAmUstqf8DbQ6z5PP7e0kQmRTF5qmeXa66RyKs8LITnq6f_6WfCrHnTFqsC0Lr57J_22rk">ISO 14040</a> and 14044 frameworks to provide directional insights into the technology's environmental profile. This phase will lay the groundwork for future work as more detailed data becomes available. The screening assessment will support Aduro's broader efforts to align its innovation strategy with the performance expectations of regulators, customers, and investors in the circular economy.
Subsequent phases of the LCA will incorporate operational data from the Company's Next Generation Process ("NGP") pilot plant, which is currently under construction. The second phase will provide a more comprehensive, ISO-compliant assessment of all relevant life cycle stages, including feedstock sourcing and downstream product pathways. A final phase is anticipated to support a comparative LCA, benchmarking the Hydrochemolytic&#x2122; process against other chemical recycling approaches.

ADUR

Aduro Clean Technologies Engages Delphi To Conduct Life Cycle Assessment Of Hydrochemolytic Technology For Waste Plastic Processing

Jefferies analyst David Chiaverini initiates coverage on Fifth Third Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FITB#NASDAQ">FITB</a>) with a Buy rating and announces Price Target of $47.

FITB

Jefferies Initiates Coverage On Fifth Third Bancorp with Buy Rating, Announces Price Target of $47

The Addition of Physical Copper to the Sprott Copper Miners ETF (COPP) Will Make COPP the Only1 ETF to Provide Investment Exposure to Physical Copper
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- &nbsp;Sprott Asset Management USA, Inc. today announced that, effective June 23, 2025, the Sprott Copper Miners ETF (COPP) will include an allocation to physical copper. This change will make COPP the only1 ETF to provide exposure to physical copper and the only1&nbsp;ETF to provide pure-play2&nbsp;exposure to large-, mid- and small-cap copper miners.
The change will result from a modification to the Sprott Copper Miners ETF's underlying index, the Nasdaq Sprott Copper MinersTM Index (NSCOPPTM). At its scheduled June semi-annual rebalance, effective at the market open on June 23, the index will add a 4.75% allocation to physical copper via the inclusion of the Sprott Physical Copper Trust, the world's first and only physical copper investment fund.

Sprott Asset Management USA Says Sprott Copper Miners ETF Will Include Allocation To Physical Copper, Effective June 23, 2025

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCY#NASDAQ">ONCY</a>) with a Buy and maintains $5 price target.

ONCY

HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $5 Price Target

MRNA

Moderna Announced That In Consultation With The U.S. Food And Drug Administration, The Company Has Voluntarily Withdrawn The Pending Biologics License Application For Mrna-1083, Its Flu/Covid Combination Vaccine Candidate For Adults Aged 50 Years And Older

Epic Games&#8216; popular battle royale game &#8220;Fortnite&#8221; has returned to Apple Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) App Store in the United States after a nearly five-year absence, marking a significant shift in the mobile app ecosystem following a federal court ruling against Apple&#8217;s payment practices.
What Happened: Fortnite became available again on Apple&#8217;s iOS systems in the U.S. on Tuesday, ending a ban that began in 2020 when Apple removed the game from its platform amid a dispute over in-app payment commissions, as reported by Reuters. 
The return follows an April 30 ruling by a federal judge stating that Apple violated a U.S. court order requiring the company to allow greater competition for app downloads and payment methods.
Epic Games CEO Tim Sweeney celebrated the return on social media platform X, posting &#8220;We back fam.&#8221; Sweeney has also <a href="https://www.benzinga.com/news/legal/25/04/45123864/apple-ordered-to-ease-app-store-rules-in-us-epic-games-ceo-tim-sweeney-proposes-peace-deal-saying-well-return-fortnite-and-drop-all-litigation-only-if">proposed a peace deal</a>, offering to return Fortnite to the App Store worldwide and abandon all litigation if Apple relaxes its App Store rules globally. He revealed that battling Apple over the past five years has cost Epic Games over $1 billion, but he believes it was worth it.
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45537919/fda-limits-annual-covid-19-boosters-to-high-risk-americans-demands-new-trials-for-healthy-adults-in-policy-shift-under-rfk-jr">FDA Limits Annual COVID-19 Boosters To High-Risk Americans, Demands New Trials For Healthy Adults In Policy Shift Under RFK Jr.</a>
Why It Matters: Apple has expressed apprehension over the potential financial consequences of the contempt ruling, warning it could lead to &#8220;substantial&#8221; financial losses estimated at <a href="https://www.benzinga.com/markets/equities/25/05/45277610/apple-warns-of-hundreds-of-millions-to-billions-dollar-losses-over-epic-games-ruling-seeks-stay-amid-app-store-shakeup">&#8220;hundreds of millions to billions&#8221;</a> of dollars annually.
The decision effectively prevents Apple from charging its usual commission of up to 30% on in-app payments for developers who direct users to alternative payment methods.
For Epic Games, this victory comes after a lengthy legal battle that began in 2020 when both Apple and Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) Google banned Fortnite from their stores over in-app payment disputes. The game had already returned to Android devices worldwide and iPhones in the European Union last year.
Image Via Shutterstock
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/global/25/05/45537805/musks-starlink-could-sidestep-south-african-equity-rules-under-deal-aimed-at-calming-relations-ahead-of-trump-meeting-report">Musk&#8217;s Starlink Could Sidestep South African Equity Rules Under Deal Aimed At Calming Relations Ahead Of Trump Meeting: Report</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Gaming

Regulations

AAPL

GOOG

GOOGL

NFLX

SPOT

Fortnite Storms Back To iPhones After 5‑Year Ban As Court Ruling Undercuts Apple's 30% App‑Store Toll

Jefferies analyst David Chiaverini initiates coverage on M&amp;T Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTB#NYSE">MTB</a>) with a Buy rating and announces Price Target of $225.

Jefferies Initiates Coverage On M&T Bank with Buy Rating, Announces Price Target of $225

The Company demonstrated strong mucoadhesion and broad surface coverage in ex vivo nasal tissue models
Raanana, Israel, May 21, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRZ#NASDAQ">PLRZ</a>) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, announced compelling results from recent ex vivo studies demonstrating the mucoadhesive strength and extensive nasal surface coverage of its proprietary formulation platform.
The studies were conducted in collaboration with Prof. Fabio Sonvico's laboratory, utilizing excised rabbit nasal mucosa as a surrogate for human nasal tissues. The research aimed to characterize two key technological aspects of Polyrizon's formulation: surface coverage capability and mucoadhesive performance, both essential properties for protection against airborne biological assaults and for effective intranasal therapeutic delivery.
Advanced ex vivo studies using two-photon fluorescence microscopy demonstrated that Polyrizon's formulation spreads rapidly and uniformly across the nasal mucosa, forming a consistent surface layer. The use of fluorescent markers confirmed that the formulation was accurately localized on the tissue, clearly distinguishable from natural tissue autofluorescence. This broad and uniform coverage is essential for ensuring effective localized protection or drug delivery. In parallel, mucoadhesion testing showed that the formulation maintains a strong and lasting attachment to the nasal tissue, even under conditions simulating physiological nasal fluid flow. This prolonged retention supports the potential for extended efficacy and enhances the potential for therapeutic benefit by helping the formulation stay in place long enough to exert its intended effect.

PLRZ

Polyrizon Announces Results From Recent Ex Vivo Studies Demonstrating Mucoadhesive Strength And Extensive Nasal Surface Coverage Of Its Proprietary Formulation Platform

New program enables issuers to enhance commercial offerings through fully integrated digital solutions
Visa (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>), a global leader in digital payments, announced Visa Commercial Integrated Partners, a new program designed to improve connectivity between fintechs and Visa Commercial products through its commercial platform. Visa will make available advanced APIs to embed Visa products in a business partners' applications and make these integrations available to its financial institution clients, allowing them to offer new, seamless payment experiences to their business customers.

Visa Announces Visa Commercial Integrated Partners, New Program To Improve Connectivity Between Fintechs And Visa Commercial Products Through Its Commercial Platform

Press Releases

Snow Lake Phase 2 Drill Program Underway at Engo Valley

Snow Lake Launches Strategic Growth Plan Targeting Investments in Solana Crypto (SOL), and Clean Energy Technologies

Snow Lake and Global Uranium and Enrichment Limited Successfully Close the Acquisition of the Pine Ridge Uranium Project

Pine Ridge Project Significantly Expanded

Snow Lake Announces Reverse Stock Split

Snow Lake to Participate in a Virtual Critical Minerals Conference Presented by Maxim Group LLC on Tuesday, May 6th at 8:30 a.m. EST

Urenco and Ubaryon to Form Strategic Partnership

Snow Lake Announces 2025 Annual General & Special Meeting Results

Snow Lake Secures Strategic Stake in North America's Largest Undeveloped Rare Earths Project Amid Global Supply Chain Pressures

Exploration Program for the Flagship Pine Ridge Uranium Project In Wyoming's Prolific Powder River Basin

LITM

TSXV:CCE

American Battery Technology Company - Common Stock

American Battery Tech

BHP Group Limited American Depositary Shares (Each representing two Ordinary Shares)

Comments

Snow Lake Resources

뉴스

에 대한 최신 뉴스 Snow Lake Resources (NASDAQ:LITM) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌